Emergent BioSolutions to Release First Quarter 2022 Financial Results and Conduct Conference Call on April 28, 2022

GAITHERSBURG, Md., April 08, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 28, 2022, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2022, recent business developments, revenue guidance for the second quarter of 2022, and financial outlook for full year 2022.

This conference call can be accessed live by telephone or by webcast:

Teleconference Information:

Dial in number – toll-free: (855) 766-6521

Dial in number – toll: (262) 912-6157

Conference ID: 3691528

Webcast Information:

Visit https://edge.media-server.com/mmc/p/84272zeqfor the live webcast.

A replay of the call can be accessed from the Investors page of the Emergent website.

About Emergent BioSolutions

Vice President, Investor Relations

Senior Director, Media Relations

EBSI earnings emergent